Maria Mar Mosquera
Overview
Explore the profile of Maria Mar Mosquera including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
101
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lopez-Perea N, Rivera Ariza S, Salom Castell M, Izquierdo Gomez C, Guillaumes M, Fernandez-Garcia A, et al.
Travel Med Infect Dis
. 2024 Oct;
62:102768.
PMID: 39370024
Contact tracing of individual exposed to any infectious measles case deserves special attention when in the country the disease is mostly imported. We present the coordinated public health actions triggered...
2.
Saez-Penataro J, Calvo G, Bascuas J, Mosquera M, Marcos M, Egri N, et al.
Vaccines (Basel)
. 2024 Jun;
12(6).
PMID: 38932394
Enhancing our comprehension of mRNA vaccines may facilitate the future design of novel vaccines aimed at augmenting immune protection while minimising reactogenic responses. Before this design is carried out, it...
3.
Pampaka D, Lopez-Perea N, Fernandez-Garcia A, Huertas-Zarco I, Castellanos-Martinez M, Villatoro-Bongiorno K, et al.
Euro Surveill
. 2023 Apr;
28(17).
PMID: 37103785
Given sustained high vaccination coverage and enhanced surveillance for measles, Spain has been free of endemic measles transmission since 2014, achieving elimination certification from the World Health Organization in 2017....
4.
Santos Bravo M, Plault N, Sanchez-Palomino S, Rodriguez C, Navarro Gabriel M, Mosquera M, et al.
J Infect Dis
. 2022 Aug;
226(9):1528-1536.
PMID: 35993155
Background: This study describes the genotypic and phenotypic characterization of novel human cytomegalovirus (HCMV) genetic variants of a cohort of 94 clinically resistant HCMV patients. Methods And Results: Antiviral-resistant mutations...
5.
Santos Bravo M, Tilloy V, Plault N, Sanchez Palomino S, Mosquera M, Navarro Gabriel M, et al.
Microbiol Spectr
. 2022 Mar;
10(2):e0019122.
PMID: 35343771
mutations in the terminase subunit and its associated phenotypes were studied in the context of cytomegalovirus (CMV) transplant recipients clinically resistant to DNA-polymerase inhibitors, naive to letermovir. R246C was the...
6.
Martinez M, Basile L, Siso-Almirall A, Cristino V, Cuesta G, Hurtado J, et al.
Infect Dis Ther
. 2021 Nov;
11(1):587-593.
PMID: 34762246
The immense impact of the COVID-19 pandemic on health systems has motivated the scientific community to search for clinical prognostic factors for SARS-CoV-2 infection. Low cycle threshold values (Ct) of...
7.
Santos Bravo M, Nicolas D, Berengua C, Fernandez M, Hurtado J, Tortajada M, et al.
J Infect Dis
. 2021 Jul;
224(8):1325-1332.
PMID: 34329473
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reverse-transcription polymerase chain reaction (RT-PCR) provides a highly variable cycle threshold (Ct) value that cannot distinguish viral infectivity. Subgenomic ribonucleic acid (sgRNA)...
8.
Guiu A, Lopez-Aladid R, Cardenoso L, Mosquera M, de la Camara R, Marcos M
Med Clin (Barc)
. 2019 Dec;
154(11):433-439.
PMID: 31785805
Introduction: Cytomegalovirus (CMV) is the most important opportunistic pathogen associated with transplant. The objective of this study was the characterization of CMV resistance mutations in allogeneic haematopoietic cell transplant recipients...
9.
Nicolas D, Suarez A, Ambrosioni J, Manzardo C, Ligero C, Costa J, et al.
Int J Infect Dis
. 2019 Aug;
88:73-79.
PMID: 31401201
Background: Severe cases of primary HIV infection have been described in patients presenting with neurological involvement, AIDS defining events or other life-threatening events. These severe forms have not been fully...
10.
Lopez-Aladid R, Guiu A, Mosquera M, Lopez-Medrano F, Cofan F, Linares L, et al.
PLoS One
. 2019 Jul;
14(7):e0219701.
PMID: 31318908
Objetives: The aim of this study was to identify CMV drug resistance mutations (DRM) in solid organ transplant (SOT) recipients with suspected resistance comparing next-generation sequencing (NGS) with Sanger sequencing...